Corindus Launches technIQ Smart Procedural Automation Series for CorPath GRX System

December 15, 2020—Corindus, a Siemens Healthineers Company, announced the global launch of a new set of automated robotic movements in the technIQ Series designed for the company’s CorPath GRX system. The company received FDA 510(k) clearance for new software automation that provides predictable and consistent movements to aid in advanced device manipulation during complex coronary and peripheral procedures.

Corindus reported that Jean Fajadet, MD, performed the first-in-human coronary procedures with the benefit of the new automated movements, which replicate manual techniques of highly skilled interventionalists. The procedures demonstrated how the new movements can help to reduce procedure time associated with wire and device manipulation and drive standardization in quality of care by offering advanced techniques to all physicians. Dr. Fajadet is the Codirector of Interventional Cardiology at Clinique Pasteur in Toulouse, France.

“This new software algorithm gives the operator new possibilities to advance and facilitate treatment, especially with complex lesions,” commented Dr. Fajadet in the Corindus announcement. “I am pleased with the success of using the automated moves and am honored to play a role in the advancement of robotic technology that will make interventional procedures more efficient and safer for our patients.”

The latest global introduction and FDA clearance for the technIQ Series provides physicians with four additional automated robotic movements that aid with complex tasks such as crossing lesions, navigating tortuosity, and precisely measuring the anatomy for appropriate device size selection.

Rotate on Retract (RoR) was the first automated robotic movement in the technIQ Series and has demonstrated the potential to significantly reduce wiring time. Corindus received CE Mark approval and FDA clearance for the RoR automated technique in 2018.